DHR US2358511028

Report

Delayed Nyse - 04:02:54 2023-02-03 pm EST
269.85	USD		-0.31%

01/30	UBS Adjusts Danaher's Price Target to $306 From $294, Maintains Buy Rating	MT
01/26	Insider Sell: Danaher	MT
01/25	Cowen Adjusts Price Target on Danaher to $320 From $340, Maintains Outperform Rating	MT

Barclays Lowers Price Target on Danaher to $277 From $285, Reiterates Overweight Rating

11/29/2022 | 07:39am EST

Stocks mentioned in the article	Change	Last	1st jan.
BARCLAYS PLC	0.13%	188.64	19.00%
DANAHER CORPORATION	-0.31%	269.85	1.98%

All news about DANAHER CORPORATION

01/30	UBS Adjusts Danaher's Price Target to $306 From $294, Maintains Buy Rating	MT
01/26	Insider Sell: Danaher	MT
01/25	Cowen Adjusts Price Target on Danaher to $320 From $340, Maintains Outperform Rating	MT
01/25	RBC Cuts Price Target on Danaher to $289 From $293, Maintains Outperform Rating	MT
01/24	Danaher Fourth-Quarter Results Top Views; Cuts COVID-19-Related Revenue From Sales Grow..	MT
01/24	Global markets live: GE, J&J, Verizon, Lockheed Martin, Halliburton...
01/24	Is the Fed losing its grip on investors?
01/24	Sector Update: Health Care Stocks Flat to Lower Pre-Bell Tuesday	MT
01/24	Sector Update: Health Care	MT
01/24	Barclays Adjusts Danaher Price Target to $290 From $277, Maintains Overweight Rating	MT

Analyst Recommendations on DANAHER CORPORATION

01/30	UBS Adjusts Danaher's Price Target to $306 From $294, Maintains Buy Rating	MT
01/25	Cowen Adjusts Price Target on Danaher to $320 From $340, Maintains Outperform Rating	MT
01/25	RBC Cuts Price Target on Danaher to $289 From $293, Maintains Outperform Rating	MT

Financials (USD)

Chart DANAHER CORPORATION

Duration : Period :

Technical analysis trends DANAHER CORPORATION

	Short Term	Mid-Term	Long Term
Trends	Neutral	Neutral	Neutral

Income Statement Evolution

More Financials

Consensus

EPS Revisions

More Estimates Revisions

Managers and Directors

Rainer M. Blair	President, Chief Executive Officer & Director
Matthew R. McGrew	Chief Financial Officer & Executive Vice President
Steven M. Rales	Chairman
Jose-Carlos Gutiérrez-Ramos	Chief Science Officer & Senior Vice President
Sadik Kassim	Chief Technology Officer

Sector and Competitors

		1st jan.	Capi. (M$)
	DANAHER CORPORATION	1.98%	196 532


THERMO FISHER SCIENTIFIC	6.73%	231 606
INTUITIVE SURGICAL, INC.	-4.02%	90 000
BOSTON SCIENTIFIC CORPORATION	3.89%	69 467
SIEMENS HEALTHINEERS AG	15.64%	65 645
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	4.75%	58 216

DANAHER CORPORATION